cln-617
Showing 1 - 1 of 1
Advanced Solid Tumor Trial in United States (CLN-617, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- CLN-617
- Pembrolizumab
-
Los Angeles, California
- +5 more
Sep 12, 2023